Interferon-alfa2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.

被引：0
|
作者：
Shakil, AO
McGuire, B
Crippin, JS
Canjeevaram, HS
Teperman, L
Gish, RG
Kwo, P
Wright, TL
Brass, C
Balan, V
Demetris, J
Rakela, J
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Alabama, Birmingham, AL USA
[3] Baylor Univ, Dallas, TX USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] New York Med Ctr, New York, NY USA
[6] Calif Pacific Med Ctr, San Francisco, CA USA
[7] Indiana Univ, Indianapolis, IN 46204 USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
[9] Integrated Therapeut Grp Inc, Kenilworth, NJ USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
221
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
  • [21] Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation
    Castedal, M
    Siewert-Delle, A
    Olausson, M
    Friman, S
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 820 - 821
  • [22] Treatment of recurrent hepatitis C after liver transplantation with Interferon alfa 2b and Ribavirin
    Zamboni, F
    Franchello, A
    Lavezzo, B
    Strignano, P
    Schellino, M
    Rizzetto, M
    Salizzoni, M
    TRANSPLANTATION, 2000, 69 (08) : S265 - S265
  • [23] Treatment of Recurrent Hepatitis C (Genotype 1) with Pegylated Interferon Alfa-2b and Ribavirin Combination and Maintenance Therapy
    Testino, Gianni
    Sumberaz, Alessandro
    Ansaldi, Filippo
    Borro, Paolo
    Leone, Silvia
    Ancarani, A. Ornella
    Gentile, Raffaella
    Icardi, Giancarlo
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 536 - 538
  • [24] Response to interferon alfa 2B and ribavirin in Hispanics with hepatitis C.
    Munoz, HJ
    Arroyo, J
    Chinea, B
    Gonzalez, H
    Rodriguez, F
    Toro, D
    Torres, E
    HEPATOLOGY, 2000, 32 (04) : 348A - 348A
  • [25] Ribavirin monotherapy in liver transplant recipients with recurrent hepatitis C
    Lionetti, R
    Tisone, G
    Di Paolo, D
    Zazza, S
    Casarelli, F
    Manzia, TM
    Petrolati, A
    Cepparalo, M
    Angelico, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 39 - 40
  • [26] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [27] Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin
    Arrigo, Richard
    Samanta, Arun
    Griffith, Shanthini
    Parekh, Ravish M.
    Korogodsky, Maria
    Rao, Kiran V.
    Fisher, Adrian
    Wilson, Dorian
    Klein, Kenneth M.
    Koneru, Baburao
    GASTROENTEROLOGY, 2011, 140 (05) : S459 - S459
  • [28] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [29] The Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C.
    Fontaine, H
    Pol, S
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1999, 23 (04): : 541 - 544
  • [30] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    HEPATOLOGY, 2002, 36 (04) : 183A - 183A
12345